Cord-cutters can watch live sports, news and original programming without having to spend hundreds of dollars through these ...

Viking Therapeutics' stock was volatile in 2025 due to clinical trial results. VK2735's oral form faced safety concerns but ...

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of $1.31 per share. The business software maker posted ...